Vigil provides a lightweight, wearable monitor that continuously records heart rate, blood oxygen saturation, temperature, and respiratory rate for general‑ward patients. By delivering near‑continuous data at a fraction of ICU‑grade monitor costs, it enables hospitals to equip many beds economically and improve early detection of clinical deterioration.
Funding
Funding not disclosed
Founders
Product
Problem
General ward patients often receive only intermittent vital sign checks, leading to delayed detection of clinical deterioration. Traditional ICU-grade monitoring systems are expensive and impractical for widespread use on regular wards, limiting continuous observation.
Solution
Vigil offers a lightweight, wearable monitor that continuously tracks heart rate, blood oxygen saturation, temperature, and respiratory rate. The device is designed for easy deployment on general wards, enabling 3–6 spot checks per patient each day while providing near‑continuous data. At roughly 45 g, it can be worn overnight without discomfort. By leveraging low‑cost sensors and a simplified hardware platform, Vigil delivers monitoring capabilities at a fraction of the price of conventional ICU monitors, allowing hospitals to equip large numbers of beds economically.
Target Audience
Primary customers are hospitals and health systems seeking to extend continuous vital sign monitoring to general ward patients, particularly those aiming to improve early detection of deterioration while controlling costs.
Features
- Integrated multi‑parameter sensors for HR, SpO₂, temperature, and respiratory rate
- Wearable form factor (~45 g) suitable for overnight use
- Enables 3–6 spot checks per day with continuous data capture
- Cost‑effective pricing: equips 200 beds for under $9,200 versus $5,000–$15,000 per traditional bedside monitor
- Scalable architecture validated in pilot deployments at multiple academic hospitals